Webinar: CGM in Pregnancy

Dexcom G7 15 Day Continuous Glucose Monitoring in Pregnancy

Date: January 7, 2026

Speaker: Sarah O'Hara, RD, CDCES

Session Overview: 

Diabetes in pregnancy is on the rise, presenting challenges in glucose management.  Continuous glucose monitoring (CGM) technology offers real-time data that enhances patient care.  The Dexcom G7 15 Day includes all the same features and capabilities of Dexcom G7, while bringing new advancements aimed at improving diabetes management.*  The session also provides resources for healthcare providers to integrate CGM into their practices for improved patient outcomes.

^{*Per clinical studies, not all sensors may last 15 days.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safetyinformation and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2025 Dexcom, Inc. All rights reserved.}

^MAT-13247